Skip to content

Exploring the mechanism of Tiao Shen Li Yan Acupuncture treatment for treating dysphagia after cerebral infarction based on brain fMRI and DTI technology

Exploring the mechanism of Tiao Shen Li Yan Acupuncture treatment for treating dysphagia after cerebral infarction based on brain fMRI and DTI technology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086748
Enrollment
Unknown
Registered
2024-07-10
Start date
2024-07-23
Completion date
Unknown
Last updated
2025-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dysphagia after cerebral infarction

Interventions

Treatment group (part 2):Tiao Shen Li Yan Acupuncture treatment
control group (part 2):Sham acupuncture treatment
Patietns group (part 1):None

Sponsors

Shenzhen Hospital (Fu Tian) of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 46 patients with dysphagia after cerebral infarction: Inclusion criteria: 1. Those who meet the above diagnostic criteria; 2.Individuals aged 30-80 years old; 3. The course of the disease is 2 weeks to 6 months; 4. Conscious, stable vital signs, able to understand and cooperate with examinations and treatments; 5. Sign the informed consent form. Normal population control group(Healthy control group): During the same period of physical examination, 20 normal individuals matched in age, gender, and education level were selected. Inclusion criteria: 1. Age range from 30 to 80 years old, overall good health condition, no neurological disorders; 2. Normal swallowing function, without clinical manifestations of swallowing disorders such as coughing and difficulty swallowing due to drinking water; 3.No history of stroke, Parkinson's disease, or dementia in the past; 4. Individuals without a history of laryngeal and pharyngeal tumors or surgery.

Exclusion criteria

Exclusion criteria: 1. Comatose patients, Parkinson's disease, and Alzheimer’s disease; 2. Severe failure of organs such as heart and kidney, or severe stroke with unstable vital signs; 3. Individuals who do not meet the above diagnostic criteria and whose imaging examination fails to detect cerebrovascular disease; 4. Those who cannot cooperate with evaluation and treatment, and have poor compliance; 5. Suffering from serious mental illness and unable to cooperate with observation and treatment; 6. Metal implants in the body cannot be used in conjunction with magnetic resonance imaging.

Design outcomes

Primary

MeasureTime frame
Brain resting fMRI;Brain DTI;

Secondary

MeasureTime frame
Standard Swallowing Function Assessment (SSA);video fluoroscopic swallowing study(VFSS);Montreal Cognitive Assessment Scale (MoCA);Swalowing-Quality of Life(SWAL-QOL);

Countries

China

Contacts

Public ContactJing Luo

Shenzhen Hospital (Fu Tian) of Guangzhou University of Chinese Medicine

312259917@qq.com+86 135 3085 5286

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026